The Synthesis, Structural Modification and Mode of Anticancer Action of Evodiamine: a review

• Published in: Recent patents on anti-cancer drug discovery
• Main Authors: Fan, Meixia, Yao, Lei
• Format: Journal Article
• Language: English
• Published: United Arab Emirates 01.01.2022
• Subjects: Antitumor; Drug design; Evodiamine; Mode of action; Patent; Synthesis; Structural Modification
• ISSN: 2212-3970
• DOI: 10.2174/1574892817666211221165739

Finding novel antitumor reagents from naturally occurring alkaloids is a widely accepted strategy. Evodiamine, a tryptamine indole alkaloid isolated from Evodia rutaecarpa, has a wide range of biological activities, such as antitumor, anti-inflammation, and anti-bacteria. Hence, research works on the structural modification of evodiamine will facilitate the discovery of new antitumor drugs. The recent advances in the synthesis of evodiamine, and studies on the drug design, biological activities, and structure-activity-relationships of its derivatives, published in patents and primary literatures, are reviewed in this paper. The literatures, including patents and follow-up research papers from 2015 to 2020, related to evodiamine is searched in the Scifinder, PubMed, Espacenet, China National Knowledge Infrastructure (CNKI), and Wanfang databases. The key words are evodiamine, synthesis, modification, anticancer, mechanism. The synthesis of evodiamine are summarized. Then, structural modifications of evodiamine are described, and the possible modes of actions are discussed. Evodiamine has a 6/5/6/6/6 ring system, and the structural modifications are focused on ring A, D, E, C5, N-13, and N-14. Some compounds show promising anticancer potentials and warrant further study.